发明名称 |
COMPOSITIONS SUPPORTIVE FOR TREATING DRUG-RESISTANCED BREAST CANCER CONTAINING MIR-500A-3P AND SENSITIZING METHOD FOR ANTICANCER REAGENT IN DRUG-RESISTANCED BREAST CANCER PATIENT |
摘要 |
The present invention relates to a method for recovering sensitivity to an anticancer agent of a breast cancer patient with anticancer agent tolerance by expressing or adding miR-500a-3p and to a treatment supplement agent including miR-500a-3p. According to the present invention, a mechanism that tolerance for an anti-hormone treatment agent such as tamoxifen as a breast cancer treatment agent is generated; activation of miR-500a-3p in a breast cancer cell with LY6K overexpression recovers sensitivity to tamoxifen by re-expression of ERα; and a method for preventing anticancer agent tolerance and recovering sensitivity to an anticancer agent. In addition, according to the present invention, a reverse correlation between LY6K and ERα. Sensitivity to tamoxifen can be increased as upward regulation of miR-500a-3p, which is induced by ERα, inhibits expression of LY6K in an ERα-negative breast cancer cell. |
申请公布号 |
KR101581721(B1) |
申请公布日期 |
2015.12.31 |
申请号 |
KR20150113745 |
申请日期 |
2015.08.12 |
申请人 |
SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION |
发明人 |
PARK, JONG HOON;KIM, YE SOL;KONG, HYUN KYUNG |
分类号 |
C12N15/86;A61K31/138;A61K48/00 |
主分类号 |
C12N15/86 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|